Skip to main content

Table 1 Demographic data

From: Long-term follow-up and quality of life in patients receiving extracorporeal membrane oxygenation for pulmonary embolism and cardiogenic shock

 

All patients (n  = 119)

Survivors (n  = 54)

Non-survivors (n  = 65)

p value

Age (years)

50.9 ± 14.8

49 ± 15

52.5 ± 14.5

0.196

Male

69 (57.9%)

30 (55.6%)

39 (60%)

0.625

BMI (kg/m2)

29 ± 14

30.3 ± 7.5

32.3 ± 10

0.246

Pre-lactate (mmol/l)

9.6 ± 6.9

6.9 ± 5.3

14.1 ± 7.2

< 0.001

Pre-norepinephrine (µg/kg/min)

0.5 ± 0.7

0.6 ± 0.5

0.5 ± 0.5

0.111

Pre-epinephrine (µg/kg/min)

0.8 ± 1.2

0.14 ± 0.3

0.2 ± 0.3

0.04

Pre-MAP (mmHg)

55 ± 17

61 ± 15

44 ± 16

< 0.001

Pre-pH

7.2 ± 0.17

7.2 ± 0.15

7.05 ± 0.2

0.005

Pre-prothrombin time (%)

60 ± 27

64 ± 24

51 ± 27

0.007

Pre-D-dimer (mg/l)

16 ± 3.8

21.3 ± 13.3

28.4 ± 12.9

0.269

Peak NSE-level (µg/l)

146 ± 171

53 ± 32

214 ± 208

0.002

Peak fHb (mg/l)

489 ± 554

278 ± 388

578 ± 642

0.007

Preimplant CPR

80 (67.2%)

31 (57.4%)

49 (75.4%)

0.039

Duration of CPR (min)

55.1 ± 32.7

46.3 ± 27.6

58.9 ± 34.3

0.158

Average ECMO support (days)

6.6 ± 8.2

7.6 ± 7.7

5.8 ± 8.6

< 0.001

ICU stay (days)

16.6 ± 18.4

25.2 ± 20.6

9.5 ± 12.5

< 0.001

Overall hospital stay (days)

20.2 ± 22.7

33 ± 25.5

9.5 ± 12.5

< 0.001

  1. Statistically significant p-values are reported in bold
  2. BMI body mass index; MAP mean arterial pressure; NSE neuron-specific enolase; fHb free plasma hemoglobin; CPR cardiopulmonary resuscitation; ICU intensive care unit